<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35163412</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1489</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23031489</ELocationID><Abstract><AbstractText>Protein kinase B2 (AKT2) is involved in various cardiomyocyte signaling processes, including those important for survival and metabolism. Coxsackievirus B3 (CVB3) is one of the most common pathogens that cause myocarditis in humans. The role of AKT2 in CVB3 infection is not yet well understood. We used a cardiac-specific AKT2 knockout (KO) mouse to determine the role of AKT2 in CVB3-mediated myocarditis. CVB3 was injected intraperitoneally into wild-type (WT) and KO mice. The mice's survival rate was recorded: survival in KO mice was significantly decreased compared with WT mice (WT vs. KO: 73.3 vs. 27.1%). Myocardial damage and inflammation were significantly increased in the hearts of KO mice compared with those of WT mice. Moreover, from surface ECG, AKT2 KO mice showed a prolonged atria and ventricle conduction time (PR interval, WT vs. KO: 47.27 &#xb1; 1.17 vs. 64.79 &#xb1; 7.17 ms). AKT2 deletion induced severe myocarditis and cardiac dysfunction due to CVB3 infection. According to real-time PCR, the mRNA level of IL-1, IL-6, and TNF-&#x3b1; decreased significantly in KO mice compared with WT mice on Days 5 after infection. In addition, innate immune response antiviral effectors, Type I interferon (interferon-&#x3b1; and &#x3b2;), and p62, were dramatically suppressed in the heart of KO mice. In particular, the adult cardiac myocytes isolated from the heart showed high induction of TLR4 protein in KO mice in comparison with WT. AKT2 deletion suppressed the activation of Type I interferon and p62 transcription in CVB3 infection. In cardiac myocytes, AKT2 is a key signaling molecule for the heart from damage through the activation of innate immunity during acute myocarditis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>So-Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ha-Hyeon</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jung-Ho</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-0441-4457</Identifier><AffiliationInfo><Affiliation>Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Eun-Seok</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine 50 Irwon dong, Gangnam-gu, Seoul 06351, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Byung-Kwan</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0003-3974-1175</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2019R1F1A1057678</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494922">Akt2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">protein kinase B2</Keyword><Keyword MajorTopicYN="N">toll-like-receptor4</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35163412</ArticleId><ArticleId IdType="pmc">PMC8836114</ArticleId><ArticleId IdType="doi">10.3390/ijms23031489</ArticleId><ArticleId IdType="pii">ijms23031489</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Park J.H., Shin H.H., Rhyu H.S., Kim S.H., Jeon E.S., Lim B.K. Vascular Endothelial Integrity Affects the Severity of Enterovirus-Mediated Cardiomyopathy. Int. J. Mol. Sci. 2021;22:3053. doi: 10.3390/ijms22063053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063053</ArticleId><ArticleId IdType="pmc">PMC8002520</ArticleId><ArticleId IdType="pubmed">33802680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.K., Peter A.K., Xiong D., Narezkina A., Yung A., Dalton N.D., Hwang K.K., Yajima T., Chen J., Knowlton K.U. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy. J. Clin. Investig. 2013;123:5146&#x2013;5151. doi: 10.1172/JCI66271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66271</ArticleId><ArticleId IdType="pmc">PMC3859391</ArticleId><ArticleId IdType="pubmed">24200690</ArticleId></ArticleIdList></Reference><Reference><Citation>Baboonian C., Davies M.J., Booth J.C., McKenna W.J. Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 1997;223:31&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9294924</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong D., Yajima T., Lim B.K., Stenbit A., Dublin A., Dalton N.D., Summers-Torres D., Molkentin J.D., Duplain H., Wessely R., et al. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation. 2007;115:94&#x2013;102. doi: 10.1161/CIRCULATIONAHA.106.631093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.631093</ArticleId><ArticleId IdType="pubmed">17190866</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K.U. Myocarditis: An Intersection Between Genetic and Acquired Causes of Human Cardiomyopathy. J. Am. Coll. Cardiol. 2017;69:1666&#x2013;1668. doi: 10.1016/j.jacc.2017.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.02.008</ArticleId><ArticleId IdType="pubmed">28359510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L.T., Jr. Myocarditis. N. Engl. J. Med. 2009;360:1526&#x2013;1538. doi: 10.1056/NEJMra0800028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0800028</ArticleId><ArticleId IdType="pmc">PMC5814110</ArticleId><ArticleId IdType="pubmed">19357408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis&#x2014;Diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670&#x2013;680. doi: 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005;17:1&#x2013;14. doi: 10.1093/intimm/dxh186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh186</ArticleId><ArticleId IdType="pubmed">15585605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Cai T.Z., Lu Y., Liu W.J., Cheng M.L., Ji Y.Q. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression. Biochemistry. 2015;80:455&#x2013;462. doi: 10.1134/S0006297915040094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297915040094</ArticleId><ArticleId IdType="pubmed">25869363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Lv J., Jiang S., Ma Z., Wang D., Hu W., Deng C., Fan C., Di S., Sun Y., et al. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7:e2234. doi: 10.1038/cddis.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.140</ArticleId><ArticleId IdType="pmc">PMC4917669</ArticleId><ArticleId IdType="pubmed">27228349</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Yusung S., Frisancho S., Barrett M., Gatewood S., Steele R., Rose N.R. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 2003;170:4731&#x2013;4737. doi: 10.4049/jimmunol.170.9.4731.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.9.4731</ArticleId><ArticleId IdType="pubmed">12707353</ArticleId></ArticleIdList></Reference><Reference><Citation>Opavsky M.A., Martino T., Rabinovitch M., Penninger J., Richardson C., Petric M., Trinidad C., Butcher L., Chan J., Liu P.P. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Investig. 2002;109:1561&#x2013;1569. doi: 10.1172/JCI0213971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI0213971</ArticleId><ArticleId IdType="pmc">PMC151008</ArticleId><ArticleId IdType="pubmed">12070303</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M., Luo H., Yanagawa B., Suarez A., Dabiri D., Zhang J., McManus B.M. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J. Virol. 2004;78:4289&#x2013;4298. doi: 10.1128/JVI.78.8.4289-4298.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.8.4289-4298.2004</ArticleId><ArticleId IdType="pmc">PMC374262</ArticleId><ArticleId IdType="pubmed">15047842</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeyrathna P., Su Y. The critical role of Akt in cardiovascular function. Vasc. Pharm. 2015;74:38&#x2013;48. doi: 10.1016/j.vph.2015.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2015.05.008</ArticleId><ArticleId IdType="pmc">PMC4659756</ArticleId><ArticleId IdType="pubmed">26025205</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T., Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: The role of PI 3-kinase and Akt. J. Mol. Cell Cardiol. 2005;38:63&#x2013;71. doi: 10.1016/j.yjmcc.2004.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2004.11.005</ArticleId><ArticleId IdType="pubmed">15623422</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBosch B., Sambandam N., Weinheimer C., Courtois M., Muslin A.J. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J. Biol. Chem. 2006;281:32841&#x2013;32851. doi: 10.1074/jbc.M513087200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M513087200</ArticleId><ArticleId IdType="pmc">PMC2724003</ArticleId><ArticleId IdType="pubmed">16950770</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., Ogawa W., del Monte F., Gwathmey J.K., Grazette L., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 2005;115:2128&#x2013;2138. doi: 10.1172/JCI23073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23073</ArticleId><ArticleId IdType="pmc">PMC1172227</ArticleId><ArticleId IdType="pubmed">16007268</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioi T., McMullen J.R., Kang P.M., Douglas P.S., Obata T., Franke T.F., Cantley L.C., Izumo S. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell Biol. 2002;22:2799&#x2013;2809. doi: 10.1128/MCB.22.8.2799-2809.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.8.2799-2809.2002</ArticleId><ArticleId IdType="pmc">PMC133704</ArticleId><ArticleId IdType="pubmed">11909972</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniyama Y., Ito M., Sato K., Kuester C., Veit K., Tremp G., Liao R., Colucci W.S., Ivashchenko Y., Walsh K., et al. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J. Mol. Cell Cardiol. 2005;38:375&#x2013;385. doi: 10.1016/j.yjmcc.2004.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2004.12.002</ArticleId><ArticleId IdType="pubmed">15698844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ock S., Lee W.S., Kim H.M., Park K.S., Kim Y.K., Kook H., Park W.J., Lee T.J., Abel E.D., Kim J. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864 Pt A:1183&#x2013;1191. doi: 10.1016/j.bbadis.2018.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.01.022</ArticleId><ArticleId IdType="pmc">PMC6342503</ArticleId><ArticleId IdType="pubmed">29378301</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y., Qu J., Xue Y.C., Liu H., Deng H., Luo H. CALCOCO2/NDP52 and SQSTM1/p62 differentially regulate coxsackievirus B3 propagation. Cell Death Differ. 2019;26:1062&#x2013;1076. doi: 10.1038/s41418-018-0185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0185-5</ArticleId><ArticleId IdType="pmc">PMC6748094</ArticleId><ArticleId IdType="pubmed">30154446</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M., Hu N., Hua Y., Xu X., Kandadi M.R., Guo R., Jiang S., Nair S., Hu D., Ren J. Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3beta-dependent inhibition of apoptosis and ER stress. Biochim. Biophys. Acta. 2013;1832:848&#x2013;863. doi: 10.1016/j.bbadis.2013.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.02.023</ArticleId><ArticleId IdType="pmc">PMC3653446</ArticleId><ArticleId IdType="pubmed">23474308</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., Liao R., Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 2002;277:22896&#x2013;22901. doi: 10.1074/jbc.M200347200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200347200</ArticleId><ArticleId IdType="pubmed">11943770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Zhu X., Xiong L., Ren J. Ablation of Akt2 prevents paraquat-induced myocardial mitochondrial injury and contractile dysfunction: Role of Nrf2. Toxicol. Lett. 2017;269:1&#x2013;14. doi: 10.1016/j.toxlet.2017.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2017.01.009</ArticleId><ArticleId IdType="pubmed">28115273</ArticleId></ArticleIdList></Reference><Reference><Citation>Babaev V.R., Hebron K.E., Wiese C.B., Toth C.L., Ding L., Zhang Y., May J.M., Fazio S., Vickers K.C., Linton M.F. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice. J. Lipid. Res. 2014;55:2296&#x2013;2308. doi: 10.1194/jlr.M050633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M050633</ArticleId><ArticleId IdType="pmc">PMC4617132</ArticleId><ArticleId IdType="pubmed">25240046</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman A.M., McNamara D. Myocarditis. N. Engl. J. Med. 2000;343:1388&#x2013;1398. doi: 10.1056/NEJM200011093431908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200011093431908</ArticleId><ArticleId IdType="pubmed">11070105</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K.U., Badorff C. The immune system in viral myocarditis: Maintaining the balance. Circ. Res. 1999;85:559&#x2013;561. doi: 10.1161/01.RES.85.6.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.85.6.559</ArticleId><ArticleId IdType="pubmed">10488059</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A., Lodge P.A. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 1986;122:284&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1888112</ArticleId><ArticleId IdType="pubmed">3004227</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.H., Vallejo J.G., Kollias G., Mann D.L. Role of the innate immune system in acute viral myocarditis. Basic Res. Cardiol. 2009;104:228&#x2013;237. doi: 10.1007/s00395-008-0765-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-008-0765-5</ArticleId><ArticleId IdType="pmc">PMC4541794</ArticleId><ArticleId IdType="pubmed">19159057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.M., Lim B.K., Ho S.H., Yun S.H., Shin J.O., Park E.M., Kim D.K., Kim S., Jeon E.S. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis. Biochem. Biophys. Res. Commun. 2006;344:765&#x2013;771. doi: 10.1016/j.bbrc.2006.03.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.03.170</ArticleId><ArticleId IdType="pubmed">16631119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragoza C., Ocampo C., Saura M., Leppo M., Wei X.Q., Quick R., Moncada S., Liew F.Y., Lowenstein C.J. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl. Acad. Sci. USA. 1998;95:2469&#x2013;2474. doi: 10.1073/pnas.95.5.2469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.5.2469</ArticleId><ArticleId IdType="pmc">PMC19377</ArticleId><ArticleId IdType="pubmed">9482909</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann D., Van Linthout S., Dhayat S., Dhayat N., Schmidt A., Noutsias M., Song X.Y., Spillmann F., Riad A., Schultheiss H.P., et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res. Cardiol. 2007;102:500&#x2013;507. doi: 10.1007/s00395-007-0673-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-007-0673-0</ArticleId><ArticleId IdType="pubmed">17909696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada H., Saito K., Kanda T., Kobayashi I., Fujii H., Fujigaki S., Maekawa N., Takatsu H., Fujiwara H., Sekikawa K., et al. Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation. 2001;103:743&#x2013;749. doi: 10.1161/01.CIR.103.5.743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.103.5.743</ArticleId><ArticleId IdType="pubmed">11156888</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006;7:131&#x2013;137. doi: 10.1038/ni1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1303</ArticleId><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res. Cardiol. 2008;103:398&#x2013;406. doi: 10.1007/s00395-008-0733-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-008-0733-0</ArticleId><ArticleId IdType="pmc">PMC2705866</ArticleId><ArticleId IdType="pubmed">18600364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.K., Yun S.H., Ju E.S., Kim B.K., Lee Y.J., Yoo D.K., Kim Y.C., Jeon E.S. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model. Virus Res. 2015;199:1&#x2013;8. doi: 10.1016/j.virusres.2014.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.11.030</ArticleId><ArticleId IdType="pubmed">25485472</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>